GX Holdings provides institutional-grade advisory for investors seeking access to elite AI, technology, and biotech deal flow. We bridge the knowledge gap so you negotiate from strength.
GX Holdings sits at the intersection of deep technology expertise and strategic investment advisory. We equip investors with the sector intelligence needed to evaluate complex opportunities in AI, biotech, and frontier technology.
Our team combines decades of operating experience in technology companies with institutional investment discipline, giving our partners an unmatched edge in sourcing, evaluating, and negotiating high-value deals.
End-to-end support from deal sourcing to portfolio optimization, designed for investors who demand depth.
Deep-dive analysis of AI architectures, biotech pipelines, and emerging tech stacks so you understand exactly what you're investing in and why it matters.
Curated access to pre-screened investment opportunities across AI infrastructure, computational biology, digital health, and deep tech verticals.
Strategic counsel during term sheet negotiations, valuation analysis, and deal structuring to ensure you enter every investment on optimal terms.
Rigorous evaluation of technology claims, IP portfolios, regulatory pathways, and competitive moats by domain experts with operating experience.
Comprehensive landscape analysis of target sectors, identifying market leaders, emerging challengers, and white-space opportunities before the crowd.
Ongoing portfolio construction guidance, risk management, and value creation planning to maximize returns across your technology and biotech positions.
Deep expertise across the highest-growth technology verticals driving the next decade of innovation.
Large language models, inference optimization, AI chips, MLOps platforms, and enterprise AI applications transforming every industry.
AI-driven drug design, genomics, CRISPR therapeutics, synthetic biology, and precision medicine platforms.
Quantum computing, autonomous systems, advanced materials, edge computing, and next-generation semiconductor technologies.
AI diagnostics, remote patient monitoring, clinical decision support, and health data infrastructure platforms.
Algorithmic trading systems, decentralized finance, RegTech, and AI-powered risk assessment platforms.
Carbon capture, alternative proteins, bio-based materials, energy storage, and sustainable manufacturing technologies.
A structured approach designed to deliver clarity and conviction at every stage of the investment lifecycle.
We assess your investment thesis, risk appetite, and sector interests to build a tailored advisory framework.
Our domain experts deliver comprehensive technology and market analysis on target opportunities.
We guide negotiations, structure terms, and ensure you enter deals from a position of informed strength.
Post-investment, we provide ongoing strategic support to maximize portfolio value and identify follow-on opportunities.
Ready to gain an edge in technology and biotech investing? Let's discuss how GX Holdings can elevate your deal flow.